ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MANO Manolete Partners Plc

145.00
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Manolete Partners Plc LSE:MANO London Ordinary Share GB00BYWQCY12 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 145.00 140.00 150.00 145.00 142.50 145.00 6,310 08:00:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Legal Services 20.75M -3.12M -0.0714 -20.31 63.45M
Manolete Partners Plc is listed in the Legal Services sector of the London Stock Exchange with ticker MANO. The last closing price for Manolete Partners was 145p. Over the last year, Manolete Partners shares have traded in a share price range of 109.50p to 250.00p.

Manolete Partners currently has 43,761,305 shares in issue. The market capitalisation of Manolete Partners is £63.45 million. Manolete Partners has a price to earnings ratio (PE ratio) of -20.31.

Manolete Partners Share Discussion Threads

Showing 726 to 749 of 1475 messages
Chat Pages: Latest  35  34  33  32  31  30  29  28  27  26  25  24  Older
DateSubjectAuthorDiscuss
08/2/2021
17:07
Recently IPO'd companies that fail to live up to their billings seem to take a long time to regain market confidence. FWIW I sold out after the RNS at a loss, I will look for better opportunities elsewhere.

For me this was a story about accumulation - profits from one set of cases leading to more cases and a general expansion of the business. Its not unlike the R rate for covid. In this case anything above 1 is welcome and the business should have grown rapidly. However it now appears that R is less than 1 - not enough new cases to sustain the growth, may be some idle time, less growth and cases and it will be much harder to rebuild the momentum

Fortunately it was only ever a small holding for me so I can take the hit and move on. Had I held more I'd probably be hoping it will recover. Perhaps over 12-18 months, but I don't think it will over the next 6-12. But what do I know, as I bought this guff in the first place.

dr biotech
08/2/2021
17:00
Sunak - possible extension of covid loan period:

Chancellor Rishi Sunak will on Monday offer relief to the 1.4m UK small businesses that borrowed money through the state-backed bounce back loan scheme by letting them repay over a much longer timescale in an effort to prevent widespread company failures.[FT]
So no spring waterfall.
Zombie companies stalk the land.
Hiding place for criminals?

The measures to make company directors personally liable for accounting errors only affects quoted companies I believe. Probably irrelevant to the vast majority of potential clients.

jonwig
08/2/2021
16:55
I would be surprised if they needed a raise as they have 30 odd million of existing cases, some of which should be settling as we speak (case duration is 11 months on average and many of their cases are more than 6 months old). That said I can't see any recovery here for some time - you're probably looking at least 6 month until insolvencies pick up and then another 6 months for them to start buying cases and generating returns from them. So potentially this time next year, although I think it could do very well beyond that for patient investors. In the meantime management have completely killed any goodwill for this share by their poor handling of the situation.
riverman77
08/2/2021
16:40
NopeLots of sells today and a big one of 116,000.It's so illiquid expect high volatility. Just hold on an look at it again in a year or two, or preferably ten. I think you'll be pleasantly surprised.
r2oo
08/2/2021
16:39
Fundraise incoming? (I have no inside knowledge, obviously)
gaiusgracchus
08/2/2021
16:04
Is anyone aware of news?
lazg
08/2/2021
15:45
Surely can't go any lower here, still sticking with my average of 215 an I'm not averaging down anymore.
inthemix
05/2/2021
09:29
In myself now - just don't look at them for a few months, then once end of furlough kicks in this should rise.
djb3
03/2/2021
10:48
Good summary JimTech. I agree this will do very well long term but can't see any meaningful recovery any time soon, probably another 6 months at earliest. I know from Burford that it can take a very long time to recover once you've lost trust of investors, which I think is the case here due to management not flagging the very sharp drop in earnings (compounded by idiotic decision to release the update at 3pm - I'm sure if they released at 7am it would have fallen maybe 10-15% rather than over 30% ).
riverman77
03/2/2021
09:48
ShareSoc Webinar with Manolete Partners PLC (MANO) 17 February 2021 @ 5pm. Register with ShareSoc for free to view
scubadiverr
03/2/2021
09:15
6 months from now I can see this doubling. Easy
bogman1
03/2/2021
07:26
I bought in on Monday for a few reasons. This is my take...
I think the previous high rating anticipated that COVID-19 related new business would come sooner than it will do.
Cash flow has always been a problem and it will continue to be 'lumpy'. That's just the nature of the business.
The institutions that sold made good returns on their IPO investments. They bought in requiring dividends and this would have been a drain on Manolete resources.
Dividends may well now be reviewed to ease cashflow.
I see Mithaq Capital as being more patient though. It is also hugely significant as they are shareholders in Burford Capital - as has previously been pointed out.
So, Mithaq Capital know the sector. Insolvency litigation is an area where Burford no longer has an offering and Manolete is the UK market leader. Consequently, a merger would make sense at some point.
Unless an offer is made I don't see the Manolete share price moving up for a while though. This slow down has spooked investors but it will pick up again when the UK government cease financial support of companies.
Manolete Management have said that this slow-down was flagged when they released their H1 results, however, this was not clear and will have created a bit of distrust amongst investors.
Consequently, it may take time to climb up again.
Just my thoughts as a private investor. DYOR.

jimtech
02/2/2021
15:59
Why is the share price stuck?
benbendan
01/2/2021
20:14
It's his beer money
jsforum
01/2/2021
15:40
That is truly pathetic. I hope Cooklin is proud of his board
schroedar
01/2/2021
12:39
Ooops, did the CFO forget to type an extra 0?
sirrux
01/2/2021
09:01
CFO spends all his pocket-money on MANO shares! The local sweet shop will be very disappointed.
tradertrev
01/2/2021
07:57
Or he hasn't got any spare cash. If he thought it too risky he wouldn't have bought any.
amt
01/2/2021
07:36
500 shares for the CFO - clearly he either thinks it’s expensive or risky at current levels?
74tom
29/1/2021
09:40
Two ways to see this:Directors trying to bolster the share price from falling further by showing their faith in company.They are confident that possible good news released in the future will raise the stock price significantly.Directors, no matter how much they earn don't lay out 10k for stock of their personal wealth lightly
r2oo
29/1/2021
09:07
Yes they can spot a bargain.
amt
29/1/2021
08:36
Meant £10k
r2oo
29/1/2021
08:35
Three directors buying £10k each of shares this morning!
r2oo
28/1/2021
20:07
Possibly, but back then MANO was really tiny and wouldn't have moved the needle for BUR. They now have a lot more cases and would now make a useful contribution to earnings.
riverman77
Chat Pages: Latest  35  34  33  32  31  30  29  28  27  26  25  24  Older

Your Recent History

Delayed Upgrade Clock